MESTI, Tanja et al. NMR Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells. Radiology and Oncology, [S. l.], v. 52, n. 4, 2018. Disponível em: https://www.radioloncol.com/index.php/ro/article/view/2963. Acesso em: 12 jun. 2026.